Perinatal-lethal Gaucher disease is very rare and is considered a variant of type 2 Gaucher disease that occurs in the neonatal period. The most distinct features of perinatal-lethal Gaucher disease are non-immune hydrops fetalis. Less common signs of the disease are hepatosplenomegaly, ichthyosis and arthrogryposis. We report a case of Gaucher's disease (type 2) diagnosed in a newborn who presented with Hydrops Fetalis.
Introduction
Gaucher disease (GD), is an autosomal recessive lysosomal storage disorder, caused by a deficiency in the enzyme glucocerebrosidase.
It is the most common of the lysosomal storage disorders. Type 2 GD, the most severe and progressive form, manifests either prenatally or in the first months of life [1] . Perinatal-lethal GD is very rare and is considered a variant of type 2 GD. The most distinct features are non-immune hydrops fetalis [2, 3] . We report a case of type 2 Gaucher's disease diagnosed in a newborn who presented with hydrops fetalis.
Patient and observation
The patient, a female newborn, was the second infant from a 31 year-old gravida 2 para 2 mother. The maternal past medical history 
Discussion
Hydrops fetalis, has been associated with several lysosomal storage disorders, including Type 2 GD [3] . Cases involving hydrops tend to be perinatal lethal disorders and the pathophysiology is not well understood [4] . Generally, when hydrops is present in Type 2 GD, the fetus dies in utero, or is delivered prematurely and dies within the first days of life [5] . In our case, there were three family histories of undiagnosed perinatal death in the same circunstances.
Our patient was intubated and maintainded under mechanical ventilation just to perform laboratory tests and enzymes studies, necessary to inform future pregnancies. When a lysosomal storage disease is suspected in a fetus or a new born because of hydrops fetalis or neonatal hepatosplenomegaly, the presence of arthrogryposis and ichthyosis should raise suspicion for GD. In our case, the infant had a shiny and thickened skin, reminiscient of a collodion-baby phenotype. This finding may have potential diagnostic importance. Patients with Type 2 GD exhibit epidermal abnormalities regardless of whether ichthyosis is clinically evident [5, 6] . The most reliable diagnostic methods are measurement of glucose rebrosidase enzymatic activity and direct sequencing of GBA1. Enzymatic assays can be performed on leukocytes, fibroblasts, or tissue samples such as liver or spleen. Genetic testing for GD by direct sequencing of GBA1 can be used to determine disease and carrier status [7] . The occurrence of an index case invites to offer genetic counselling to parents. Unusual mechanisms including de novo mutations have been described in patients with GD [8] . Thus the recurrence risk is not always obvious. In the presented case, the parents were heterozygous for GD, with a significant risk of recurrence of the disease in their offspring. The diagnosis has allowed genetic counselling in the next pregnancy.
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Conclusion
A greater physician awareness of hydrops fetalis as a possible clinical presentation of GD will allow early recognition and therefore prompt diagnosis, moreover it will allow better estimation of the incidence of this disease. An accurate and timely diagnosis of GD is critical for genetic counselling, patient and family management that can inform future pregnancies. 
